Protagenic Therapeutics Inc (PTIX)
1.45
-0.12
(-7.57%)
USD |
NASDAQ |
Apr 26, 14:25
Protagenic Therapeutics Free Cash Flow (Quarterly): -1.238M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.238M |
| September 30, 2023 | -0.7116M |
| June 30, 2023 | -1.532M |
| March 31, 2023 | -0.3718M |
| December 31, 2022 | -0.1809M |
| September 30, 2022 | -0.5352M |
| June 30, 2022 | -0.8471M |
| March 31, 2022 | -0.4306M |
| December 31, 2021 | -0.4051M |
| September 30, 2021 | -1.075M |
| June 30, 2021 | -0.7104M |
| March 31, 2021 | -0.6077M |
| December 31, 2020 | -0.3209M |
| September 30, 2020 | -0.5178M |
| June 30, 2020 | -0.1457M |
| March 31, 2020 | -0.3644M |
| December 31, 2019 | -0.1494M |
| September 30, 2019 | -0.0618M |
| June 30, 2019 | -0.0808M |
| March 31, 2019 | -0.196M |
| December 31, 2018 | -0.3078M |
| September 30, 2018 | -0.1596M |
| June 30, 2018 | -0.3448M |
| March 31, 2018 | -0.259M |
| December 31, 2017 | -0.417M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.3588M |
| June 30, 2017 | -0.2469M |
| March 31, 2017 | -0.3574M |
| December 31, 2016 | -0.3418M |
| September 30, 2016 | -0.2961M |
| June 30, 2016 | -0.4451M |
| March 31, 2016 | -0.0574M |
| December 31, 2015 | -0.106M |
| September 30, 2015 | -0.102M |
| June 30, 2015 | -0.095M |
| March 31, 2015 | -0.093M |
| December 31, 2014 | -0.111M |
| September 30, 2014 | -0.08M |
| June 30, 2014 | -0.087M |
| March 31, 2014 | -0.116M |
| December 31, 2013 | -0.151M |
| September 30, 2013 | -0.437M |
| September 30, 2011 | -0.294M |
| June 30, 2011 | -3.596M |
| March 31, 2011 | -4.771M |
| December 31, 2010 | 1.717M |
| September 30, 2010 | -3.377M |
| June 30, 2010 | -5.195M |
| March 31, 2010 | -4.436M |
| December 31, 2009 | -0.675M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.532M
Minimum
Jun 2023
-0.0618M
Maximum
Sep 2019
-0.5414M
Average
-0.4306M
Median
Mar 2022
Free Cash Flow (Quarterly) Benchmarks
| Ekso Bionics Holdings Inc | -1.627M |
| Eyenovia Inc | -6.467M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |